Global Regulatory Database
A curated, searchable reference directory of pharmaceutical storage and distribution regulations across WHO, FDA, PIC/S, SAHPRA, USP, EMA, ISPE, and ISO frameworks. Select any record to view a plain-language summary and compliance rationale.
Showing 25 of 25 records
WHO TRS 1025 Annex 7 — Good Distribution Practices for Medical Products
The most current WHO guidance on Good Distribution Practices, replacing and superseding earlier WHO GDP guidance. Covers the entire supply chain from manufacturer to end user, addressing premises, equipment, documentation, operations, complaints and returns, self-inspections, transportation, and temperature-controlled distribution. Provides specific guidance on qualification of cold chain equipment and monitoring requirements.
WHO TRS 961 Annex 9 — Model Guidance for the Storage and Transport of Time and Temperature Sensitive Pharmaceutical Products
Provides detailed model guidance for the storage and transport of time- and temperature-sensitive pharmaceutical products. Addresses equipment qualification, temperature monitoring, alarm management, training, and documentation. Introduces the concept of Mean Kinetic Temperature (MKT) for assessing product impact during excursions. Particularly relevant for products requiring cold chain management throughout the distribution network.
WHO TRS 992 Annex 5 — WHO Technical Report Series: Supplementary Guidelines on Good Manufacturing Practices — Validation (Appendix 7: Non-sterile Process Validation) with specific relevance to temperature mapping
Addresses the qualification and validation requirements for storage and distribution areas, including thermal mapping protocols for warehouses, cold rooms, and refrigerated units. Specifies requirements for sensor placement rationale, worst-case mapping conditions, seasonal mapping, and the documentation requirements for qualification reports. Provides guidance on acceptable temperature uniformity criteria and re-qualification triggers.
PIC/S PE 011 — Guide to Good Distribution Practice for Medicinal Products
The PIC/S GDP guideline provides harmonised guidance for wholesale distributors of medicinal products in PIC/S member states. Covers organisational structure, personnel, premises and equipment, documentation, operations (receipt, storage, supply), returns, counterfeits, complaints, transportation, and quality management. Aligned with EU GDP guidelines but with additional technical detail on equipment qualification and temperature control requirements.
EU Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 343/01)
The European Commission's legally enforceable GDP guidelines set the baseline for all wholesale distributors of human medicinal products operating within the European Economic Area. Addresses quality system, personnel, premises and equipment, documentation, operations, complaints and returns, self-inspection, transportation, and broker requirements. The 2013 revision significantly strengthened temperature control requirements and introduced explicit cold chain obligations.
SAHPRA Good Distribution Practice Guidelines for Medicines and Scheduled Substances
SAHPRA's national GDP guideline for wholesale distributors and warehouse operators dealing in medicines and scheduled substances in South Africa. Based on PIC/S PE 011 with local regulatory adaptations. Covers licensing requirements, premises standards, personnel qualifications, cold chain management, documentation, and inspection expectations. Provides specific guidance on SAHPRA licence application requirements and the documentation expected at inspection.
FDA 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
The US federal regulation governing current Good Manufacturing Practices for finished pharmaceutical products. Subpart J (Records and Reports) and Subpart B (Buildings and Facilities) are particularly relevant to storage, including requirements for adequate temperature control, equipment qualification, and record-keeping. The 2023 version incorporates updates addressing data integrity and electronic records.
USP Chapter <1079> — Good Storage and Distribution Practices for Drug Products
A comprehensive USP informational chapter providing detailed good practice guidance for storage and distribution of drug products. Covers facility design, equipment qualification, temperature monitoring, personnel training, complaint handling, and transportation. Includes specific guidance on temperature mapping, sensor placement, and acceptable operating ranges. Provides guidance on MKT calculation and excursion assessment.
USP Chapter <659> — Packaging and Storage Requirements
Defines the standard storage conditions referenced in USP drug product monographs, including precise temperature ranges for controlled room temperature (CRT), refrigerated, frozen, and ultra-cold storage. Also addresses packaging requirements and the definition of controlled and uncontrolled temperature environments. The CRT definition incorporates MKT with an upper limit of 25°C and allows short periods of up to 40°C.
ICH Q10 — Pharmaceutical Quality System
Establishes the framework for a harmonised pharmaceutical quality system applicable across the product lifecycle. Addresses management responsibilities, process performance and product quality monitoring, CAPA, change management, and management review. Introduces the concept of quality risk management as an enabler of effective quality system design. Although focused on manufacturing, its quality system principles are referenced in GDP and GWP contexts.
ISPE Good Practice Guide: Cold Chain Management
A comprehensive ISPE good practice guide providing detailed technical guidance on the design, qualification, operation, and management of pharmaceutical cold chain systems. Covers passive and active packaging solutions, temperature mapping of storage and transport systems, risk assessment methodologies for cold chain operations, and qualification requirements. Includes practical guidance on excursion investigation and product impact assessment.
ISPE Baseline Guide Volume 5: Commissioning and Qualification
The ISPE Baseline Guide for Commissioning and Qualification defines industry best practice for the qualification lifecycle, from User Requirement Specification (URS) through IQ, OQ, and PQ. Introduces the concept of Good Engineering Practice (GEP) and the Critical Aspects approach to qualification. Provides guidance on the qualification of HVAC systems, controlled environment areas, and temperature-controlled equipment.
PDA Technical Report 39 — Guidance for Temperature Controlled Medicinal Products: Maintaining the Quality of Temperature Sensitive Medicinal Products through the Transportation Environment
Provides comprehensive guidance on maintaining temperature control throughout pharmaceutical transportation, covering risk assessment, lane qualification, packaging selection and qualification, monitoring, and regulatory expectations. Addresses both air and road transport environments and provides practical guidance on the use of thermal challenge testing for packaging qualification. Includes guidance on transport lane mapping and worst-case scenario testing.
PDA Technical Report 53 — Guidance for Industry: Stability Testing to Support Distribution of New Drug Products
Provides a risk-based framework for designing distribution stability studies and excursion assessments. Addresses the use of accelerated and intermediate stability data to assess product impact following temperature deviations during distribution. Provides guidance on the statistical approach to excursion risk assessment and the development of product-specific excursion handling procedures.
WHO TRS 1010 Annex 10 — Guidance on Testing of Medicines Subject to Prequalification
Provides updated guidance on stability testing zones and conditions for medicines subject to WHO prequalification. Defines the four ICH climatic zones and their relevance to stability study design. Includes specific guidance on Zone IVb (hot and humid conditions) relevant to Sub-Saharan African markets. Addresses storage condition claims, label requirements, and acceptable out-of-specification handling.
IATA Perishable Cargo Regulations — Temperature Controlled Pharmaceutical Cargo
The IATA Perishable Cargo Regulations (PCR) set the standards for the air transport of temperature-sensitive pharmaceutical products. Includes requirements for packaging design and qualification, temperature monitoring during air freight, dry ice and liquid nitrogen handling, labelling, and documentation. The Time and Temperature Sensitive (TTSI) label system is defined in the PCR, as are the responsibilities of airlines, freight forwarders, and shippers.
ICH Q9 — Quality Risk Management
The international standard for quality risk management in the pharmaceutical industry. Introduces systematic risk management tools including FMEA, FTA, HACCP, and risk ranking and filtering. Provides a framework for risk-based decision making across the product lifecycle, including storage, distribution, monitoring system qualification, and CAPA prioritisation. Establishes the principle that the level of effort applied to quality activities should be commensurate with risk.
Medicines and Related Substances Act 101 of 1965 (as amended)
The primary South African legislation governing the registration, manufacture, sale, and control of medicines and related substances. Sections relevant to storage and distribution include provisions on wholesale distribution licensing, storage conditions, and record-keeping. SAHPRA's authority to set GDP guidelines, conduct inspections, and impose penalties derives from this Act. Recent amendments extend SAHPRA's powers over complementary medicines and medical devices.
ISO/IEC 17025:2017 — General Requirements for the Competence of Testing and Calibration Laboratories
Specifies the general requirements for the competence, impartiality, and consistent operation of testing and calibration laboratories. Critical to pharmaceutical storage in the context of temperature sensor calibration — organisations using calibration services for monitoring sensors must ensure their calibration provider is ISO/IEC 17025 accredited to ensure traceability of calibration results. Covers measurement uncertainty, reference standards, calibration procedures, and certificate requirements.
MHRA Guidance on Good Manufacturing Practice for Medicinal Products: Data Integrity
MHRA's guidance on data integrity expectations for GxP computerised systems, based on the ALCOA+ framework (Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, Available). Applies to all GxP electronic records including temperature monitoring data, audit trails, and calibration records. Covers access control, audit trail configuration, data export integrity, and computer system validation expectations.
FDA 21 CFR Part 11 — Electronic Records; Electronic Signatures
The US federal regulation establishing the criteria under which electronic records and electronic signatures may be considered equivalent to paper records and handwritten signatures. Covers access control, audit trails, system validation, record retention, authority checks, and training requirements. Part 11 compliance is required for any computerised system used to create, modify, maintain, archive, retrieve, or transmit FDA-required records.
WHO TRS 999 Annex 5 — Guidance on Good Data and Record Management Practices
WHO's guidance on good data and record management practices for GxP environments. Based on ALCOA+ principles and addressing paper and electronic records. Covers data lifecycle management, hybrid systems, audit trail requirements, backup and recovery, data review, and governance. Particularly relevant for temperature monitoring systems where automated data capture is used alongside manual records.
ISPE GAMP 5 — A Risk-Based Approach to Compliant GxP Computerised Systems (2nd ed.)
The industry standard for the validation of computerised systems used in GxP environments. GAMP 5 provides a risk-based, lifecycle approach to computer system validation (CSV), covering system categories, validation planning, testing strategies, infrastructure qualification, and supplier assessment. The 2022 second edition incorporates updates on agile development, cloud-hosted systems, and data integrity requirements.
PIC/S PI 041 — Draft Guidance on Data Integrity
PIC/S guidance on data integrity for GxP environments, harmonised with MHRA and WHO data integrity principles. Covers ALCOA+ principles, hybrid data systems, computerised system controls, audit trail review, data governance, and management responsibilities. Specifically addresses the responsibilities of management in creating a culture of data integrity and the quality risk management approach to data integrity gaps.
SAHPRA/EPI Cold Chain Management Guidelines for Vaccines and Biological Products
SAHPRA's specific guidelines for cold chain management of vaccines and biological products in South Africa. Covers WHO PQS (Performance, Quality and Safety) equipment standards for the public sector vaccine cold chain, as well as private sector requirements for biological product storage. Addresses cold room design, monitoring requirements, backup power, qualified personnel, temperature mapping, and regulatory reporting requirements for cold chain failures.